BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 7588920)

  • 1. Neurohormonal changes after acute myocardial infarction. Relationships with haemodynamic indices and effects of ACE inhibition.
    Foy SG; Crozier IG; Richards AM; Nicholls MG; Turner JG; Frampton CM; Ikram H
    Eur Heart J; 1995 Jun; 16(6):770-8. PubMed ID: 7588920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early neurohormonal effects of trandolapril in patients with left ventricular dysfunction and a recent acute myocardial infarction: a double-blind, randomized, placebo-controlled multicentre study.
    Sigurdsson A; Eriksson SV; Hall C; Kahan T; Swedberg K
    Eur J Heart Fail; 2001 Jan; 3(1):69-78. PubMed ID: 11163738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril.
    Rouleau JL; Packer M; Moyé L; de Champlain J; Bichet D; Klein M; Rouleau JR; Sussex B; Arnold JM; Sestier F
    J Am Coll Cardiol; 1994 Sep; 24(3):583-91. PubMed ID: 7915733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurohormonal activation and congestive heart failure: today's experience with ACE inhibitors and rationale for their use.
    Sigurdsson A; Swedberg K
    Eur Heart J; 1995 Dec; 16 Suppl N():65-72. PubMed ID: 8682064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study.
    Vantrimpont P; Rouleau JL; Ciampi A; Harel F; de Champlain J; Bichet D; Moyé LA; Pfeffer M
    Eur Heart J; 1998 Oct; 19(10):1552-63. PubMed ID: 9820995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction.
    Motwani JG; McAlpine H; Kennedy N; Struthers AD
    Lancet; 1993 May; 341(8853):1109-13. PubMed ID: 8097802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of early administration of enalapril on radionuclide left ventricular ejection fraction and plasma N-terminal atrial natriuretic peptide after acute myocardial infarction.
    Kettunen RV; Vuolteenaho O; Ukkola O; Lilja M; Jounela A; Kesäniemi YA; Leppäluoto J; Heikkilä J
    Am J Cardiol; 1994 May; 73(12):865-7. PubMed ID: 8184809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurohormonal effects of early treatment with enalapril after acute myocardial infarction and the impact on left ventricular remodelling.
    Sigurdsson A; Held P; Swedberg K; Wall B
    Eur Heart J; 1993 Aug; 14(8):1110-7. PubMed ID: 8404942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study).
    Foy SG; Crozier IG; Turner JG; Richards AM; Frampton CM; Nicholls MG; Ikram H
    Am J Cardiol; 1994 Jun; 73(16):1180-6. PubMed ID: 8203335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of enalapril on plasma atrial natriuretic peptide in late recovery phase of acute myocardial infarction.
    Hirvonen T; Remes J; Mustonen J; Tikkanen I; Tenhunen M; Pyörälä K
    Ann Med; 1991 Aug; 23(3):271-5. PubMed ID: 1834093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular volumes, ejection fraction, and plasma proatrial natriuretic factor (1-98) after withdrawal of enalapril treatment initiated early after myocardial infarction. CONSENSUS II Multi-Echo Study Group.
    Bonarjee VV; Omland T; Nilsen DW; Carstensen S; Berning J; Edner M; Caidahl K
    Br Heart J; 1995 Jun; 73(6):506-10. PubMed ID: 7626347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of tissue affinity of angiotensin-converting enzyme inhibitors on left ventricular remodeling after myocardial infarction.
    Konermann M; Altmann C; Laschewski F; Josephs W; Odenthal HJ; Horstmann E; Sanner B
    Clin Cardiol; 1998 Apr; 21(4):277-85. PubMed ID: 9562938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, tolerability, and neurohormonal changes of the combination captopril plus losartan in the early postinfarction period: a pilot study.
    Di Pasquale P; Bucca V; Scalzo S; Paterna S
    Cardiovasc Drugs Ther; 1998 May; 12(2):211-6. PubMed ID: 9652880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of early converting enzyme inhibition on neurohumoral activation in acute myocardial infarction.
    Omland T; Aarsland T; Aakvaag A; Dickstein K
    Int J Cardiol; 1993 Nov; 42(1):37-45. PubMed ID: 8112904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms involved in cardiac enlargement and congestive heart failure development after acute myocardial infarction.
    Kleber FX; Nussberger J; Niemöller L; Doering W
    Cardiology; 1992; 81(4-5):213-20. PubMed ID: 1301246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early treatment with captopril after acute myocardial infarction.
    Ray SG; Pye M; Oldroyd KG; Christie J; Connelly DT; Northridge DB; Ford I; Morton JJ; Dargie HJ; Cobbe SM
    Br Heart J; 1993 Mar; 69(3):215-22. PubMed ID: 8461219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a new angiotensin-converting enzyme inhibitor, alacepril, on changes in neurohormonal factors and arterial baroreflex sensitivity in patients with congestive heart failure.
    Kinugawa T; Kato M; Mori M; Endo A; Kato T; Hamada T; Noguchi N; Omodani H; Osaki S; Ogino K; Miyakoda H; Hisatome I; Shigemasa C
    Eur J Clin Pharmacol; 1998 May; 54(3):209-14. PubMed ID: 9681661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Captopril adjuvant therapy to beta-blockers and nitrates improves post-myocardial infarction left ventricular performance.
    Kyriakidis M; Antonopoulos A; Georgiou E; Santas P; Bakirtzis C; Toutouzas P
    Eur Heart J; 1996 Jun; 17(6):864-73. PubMed ID: 8781825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the addition of losartan improve the beneficial effects of ACE inhibitors in patients with anterior myocardial infarction? A pilot study.
    Di Pasquale P; Bucca V; Scalzo S; Cannizzaro S; Giubilato A; Paterna S
    Heart; 1999 Jun; 81(6):606-11. PubMed ID: 10336919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.